PRR12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.893200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.599200E-01
Normal-vs-Stage2
6.339400E-01
Normal-vs-Stage3
3.918800E-01
Normal-vs-Stage4
7.560400E-01
Stage1-vs-Stage2
4.456000E-01
Stage1-vs-Stage3
1.372020E-01
Stage1-vs-Stage4
6.231200E-01
Stage2-vs-Stage3
2.001000E-01
Stage2-vs-Stage4
2.619200E-01
Stage3-vs-Stage4
1.566370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.829000E-01
Normal-vs-AfricanAmerican
7.362400E-01
Normal-vs-Asian
8.426600E-01
Caucasian-vs-AfricanAmerican
8.948000E-01
Caucasian-vs-Asian
8.388600E-01
AfricanAmerican-vs-Asian
8.507000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.200800E-01
Normal-vs-Female
4.971200E-01
Male-vs-Female
1.594580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.666800E-01
Normal-vs-Age(41-60Yrs)
7.377800E-01
Normal-vs-Age(61-80Yrs)
6.880600E-01
Normal-vs-Age(81-100Yrs)
4.786400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.975200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.367800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.811200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.870000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.418600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.991800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.277400E-01
Normal-vs-Daily Drinker
7.841000E-01
Normal-vs-Weekly Drinker
8.703400E-01
Normal-vs-Occasional Drinker
7.301000E-01
Normal-vs-Social Drinker
6.424400E-01
Non Drinker-vs-Daily Drinker
6.701600E-01
Non Drinker-vs-Weekly Drinker
6.618800E-01
Non Drinker-vs-Occasional Drinker
8.534300E-02
Non Drinker-vs-Social Drinker
5.406000E-01
Daily Drinker-vs-Weekly Drinker
9.236800E-01
Daily Drinker-vs-Occasional Drinker
2.085400E-01
Daily Drinker-vs-Social Drinker
2.819600E-01
Weekly Drinker-vs-Occasional Drinker
3.640000E-01
Weekly Drinker-vs-Social Drinker
4.115000E-01
Occasional Drinker-vs-Social Drinker
4.392000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.329700E-02
Normal-vs-Grade 2
1.935510E-02
Normal-vs-Grade 3
6.476400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.894800E-01
Grade 1-vs-Grade 3
1.550040E-01
Grade 1-vs-Grade 4
9.329700E-02
Grade 2-vs-Grade 3
5.772500E-02
Grade 2-vs-Grade 4
1.935510E-02
Grade 3-vs-Grade 4
6.476400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.721800E-01
Normal-vs-NonDiabetic
8.385000E-01
Diabetic-vs-NonDiabetic
2.355000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.087000E-01
Normal-vs-NoPancreatitis
7.634200E-01
Pancreatitis-vs-NoPancreatitis
7.196600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.194000E-01
Normal-vs-N1
5.979600E-01
N0-vs-N1
3.085800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.855200E-01
Normal-vs-TP53-NonMutant
7.700600E-01
TP53-Mutant-vs-TP53-NonMutant
5.584300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
